Somnomed Limited (AU:SOM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
SomnoMed Limited has undergone significant changes with the appointment of co-CEOs Karen Borg and Amrita Blickstead, who have driven growth and operational improvements. The company reported FY24 revenue of $91.7 million and has focused on strengthening its manufacturing capabilities to meet rising product demand. With recent FDA clearance of its innovative Rest Assure® device, SomnoMed aims for continued growth and improved financial stability.
For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue